Flexion Therapeutics Inc (FLXN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

10 MALL ROAD BURLINGTON, MA 01803

Flexion Therapeutics Inc discovers and develops therapeutics for musculoskeletal disorders. The company offers pharmaceuticals and developed delivery systems for the treatment of refractory end-stage pain.

Data as of 2021-05-08 11:27:17 -0400
Market Cap365.576 Million Shares Outstanding49.942 Million Avg 30-day Volume1.188 Million
P/E Ratio-3.2151 Dividend Yield EPS-2.53
Price/Sales4.27 Debt to Equity-15.12 EBITDA-89.677 Million
Price to Book Value-21.94 Forward PE-3.95 Enterprise Value414.002 Million
Total Cash175.28 Million Current Debt55.268 Million Gross Profit66.303 Million
BETA1.4525 52-week High/Low14.39 / 7.19 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from FLXN instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 3 (0.18%) 2 (0.12%) 50.0%
Funds Holding: 140 133 5.26% 36 (2.16%) 40 (2.49%) -10.0%
13F shares: 50.24 Million 49.688 Million 1.11% 16.011 Million 16.345 Million -2.04%
% Ownership 32.4668 33.1437 -2.04%
New Positions: 26 18 44.44% 5 7 -28.57%
Increased Positions 45 45 0.0% 13 13 0.0%
Closed Positions 19 10 90.0% 9 5 80.0%
Reduced Positions 39 42 -7.14% 13 16 -18.75%
Total Calls 107.858 Thousand 135.137 Thousand -20.19% 46.4 Thousand 35.3 Thousand 31.44%
Total Puts 282.267 Thousand 272.243 Thousand 3.68% 189.1 Thousand 190 Thousand -0.47%
PUT/CALL Ratio 2.62 2.01 30.35% 4.08 5.38 -24.16%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding FLXN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FLXN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

4.5 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LAYMAN MELISSA CHIEF COMMERCIAL OFFICER

  • Officer
103,956 2021-03-15 3

CLAYMAN MICHAEL D. PRESIDENT AND CEO

  • Officer
  • Director
1,293,342 2021-03-01 7

LEVINE MARK S. GENERAL COUNSEL

  • Officer
157,431 2021-03-01 4

KELLEY SCOTT CHIEF MEDICAL OFFICER

  • Officer
163,549 2021-03-01 4

WENTWORTH KERRY CHIEF REGULATORY OFFICER

  • Officer
169,767 2021-03-01 4

ARKOWITZ DAVID CHIEF FINANCIAL OFFICER

  • Officer
242,948 2021-03-01 4

WILLWERTH CHRISTINA CHIEF STRATEGY OFFICER

  • Officer
165,186 2021-03-01 4

MUZIKANT ADAM CHIEF BUSINESS OFFICER

  • Officer
123,455 2021-03-01 3

COLELLA SAMUEL D

  • Director
77,785 2021-01-15 3

KWO ELIZABETH

  • Director
0 2020-08-18 2

MILINAZZO ALAN

  • Director
22,950 2020-07-09 2

MAHATME SANDESH

  • Director
4,500 2020-06-10 1

CANUTE SCOTT A

  • Director
4,500 2020-06-10 1

MAHAFFY PATRICK J

  • Director
35,324 2020-06-10 1

LUKATCH HEATH

  • Director
4,500 2020-06-10 1

MERRIFIELD C ANN

  • Director
14,500 2020-06-10 1

STEJBACH MARK

  • Director
8,131 2020-06-10 2

BODICK NEIL CHIEF SCIENTIFIC OFFICER

  • Officer
489,836 2020-01-03 0

DENIZ YAMO CHIEF MEDICAL OFFICER

  • Officer
9,000 2017-08-28 0

DRISCOLL FREDERICK W CHIEF FINANCIAL OFFICER

  • Officer
7,777 2017-03-23 0

VERSANT VENTURES III, LLC

VERSANT VENTURE CAPITAL III, L.P.

VERSANT SIDE FUND III, L.P.

VERSANT DEVELOPMENT FUND III, L.P.

ATWOOD BRIAN G

COLELLA SAMUEL D

JAFFE ROSS A MD

LINK WILLIAM J PHD

MILDER DONALD B

ROBERTSON REBECCA B

  • 10% Owner
3,921,092 2016-06-08 0

LUBASH BARBARA N

BOLZON BRADLEY J PHD

WARDEN CHARLES M

PRAEGER ROBIN L.

  • 10% Owner
3,921,092 2016-06-08 0

NOVO A/S

  • 10% Owner
No longer subject to file 2015-06-18 0

SOFINNOVA PARTNERS SAS

  • 10% Owner
No longer subject to file 2014-10-29 0

VERSANT VENTURE CAPITAL III, L.P.

VERSANT VENTURES III, LLC

VERSANT SIDE FUND III, L.P.

ATWOOD BRIAN G

COLELLA SAMUEL D

JAFFE ROSS A MD

LINK WILLIAM J PHD

MILDER DONALD B

LUBASH BARBARA N

ROBERTSON REBECCA B

  • Director
  • 10% Owner
2,250 2014-09-10 0

VERSANT VENTURE CAPITAL III, L.P.

BOLZON BRADLEY J PHD

WARDEN CHARLES M

VERSANT DEVELOPMENT FUND III, L.P.

  • Director
  • 10% Owner
2,250 2014-09-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LAYMAN MELISSA - Officer CHIEF COMMERCIAL OFFICER

2021-03-16 17:11:40 -0400 2021-03-15 S 4,520 $11.80 d 103,956 direct -5.4905 -18.6319 -27.0927 0.0 1 -27.0927 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
FLEXION THERAPEUTICS INC FLXN 2021-05-10 22:15:04 UTC -0.2872 0.3372 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 21:45:02 UTC -0.3123 0.3623 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 21:15:02 UTC -0.3123 0.3623 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 20:45:03 UTC -0.3095 0.3595 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 20:15:03 UTC -0.3095 0.3595 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 19:45:03 UTC -0.3095 0.3595 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 19:15:03 UTC -0.3095 0.3595 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 18:45:03 UTC -0.3147 0.3647 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 18:15:03 UTC -0.3147 0.3647 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 17:45:02 UTC -0.3147 0.3647 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 17:15:03 UTC -0.3147 0.3647 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 16:45:03 UTC -0.3147 0.3647 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 16:15:03 UTC -0.3147 0.3647 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 15:45:03 UTC -0.3147 0.3647 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 15:15:03 UTC -0.3147 0.3647 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 14:45:04 UTC -0.2622 0.3122 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 14:15:04 UTC -0.2622 0.3122 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 13:45:04 UTC -0.2622 0.3122 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 13:15:03 UTC -0.2622 0.3122 350000
FLEXION THERAPEUTICS INC FLXN 2021-05-10 12:45:02 UTC -0.2622 0.3122 350000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio FLXN -5700.0 shares, $-65778.0 2020-12-31 N-PORT
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio FLXN -4456.0 shares, $-51422.24 2020-12-31 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund FLXN -31569.0 shares, $-364306.26 2020-12-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund FLXN -243.0 shares, $-1912.41 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund FLXN -9.0 shares, $-70.83 2020-03-31 N-PORT
AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund FLXN -193.0 shares, $-2645.07 2019-09-30 N-PORT
FORUM FUNDS- ABSOLUTE CONVERTIBLE ARBITRAGE FUND FLXN -37900.0 shares, $-437366.0 2020-12-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund FLXN -240.0 shares, $-1888.8 2020-03-31 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund FLXN -15475.0 shares, $-178581.5 2020-12-31 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund FLXN -5987.0 shares, $-72861.79 2021-01-29 N-PORT
Alger Funds II- Alger Dynamic Opportunities Fund FLXN -178425.0 shares, $-2171432.25 2021-01-31 N-PORT
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund FLXN -25477.0 shares, $-280756.54 2021-02-26 N-PORT

Elevate your investments